In recent weeks, Health and Human Services Secretary Robert F. Kennedy Jr. has begun to dismantle decades of vaccine safety ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...

The Centers for Disease Control and Prevention's vaccine advisory committee voted on Thursday to recommend infants receive a ...

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

It causes cold symptoms, affecting the breathing passages and lungs, according to the CDC. In the United States, about 58,000 children younger than 5 are hospitalized for RSV each year, and ...

The CDC’s Advisory Committee on Immunization Practices (ACIP) has blessed Merck’s new respiratory syncytial virus (RSV) shot ...

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.

According to the CDC, RSV is the leading cause of infant hospitalization in the U.S. It’s estimated that 58,000-80,000 children younger than five years old are hospitalized each year due to RSV.

The CDC has published updated recommendations for older adults, detailing who should get vaccinated against RSV. The move comes after concerns were raised earlier this year that the shot may be ...

The last time RSV levels in the water were rated as "high," was during the weeks ending Dec. 30, 2023 and Jan. 6, 2024, according to the CDC. An estimated 22,000 to 45,000 people were hospitalized ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that infects the nose, throat, and lungs.According to the CDC, RSV symptoms make it difficult to distinguish it from the common ...

RSV can also cause more severe illness such as bronchiolitis and pneumonia, the CDC added. It is the most common cause of bronchiolitis and pneumonia in children younger than 1. According to the ...